Evidence map›Paper›PMID 25387017›Full record

ReviewAnnual review of animal biosciences2013

Genetically engineered pig models for human diseases.

Randall S Prather, Monique Lorson, Jason W Ross, Jeffrey J Whyte, Eric Walters

Open access · greenAbstract readReview
In one paragraph

Review in Annual review of animal biosciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 172 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Experimental Animal Models of Phenylketonuria: Pros and Cons.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Randall S PratherDivision of Animal Science, National Swine Resource and Research Center, and.
Monique Lorson
Jason W Ross
Jeffrey J Whyte
Eric Walters
Iowa State University · USUniversity of Missouri · US

Funding

Resource Core for National Swine Resource and Research Center (NSRRC) Years 21-25U42OD011140 · OD · UNIVERSITY OF MISSOURI-COLUMBIA · PI RANDALL S PRATHER · 2012 to 2026
$26.7M
NSRRC SUPPLEMENT FOR DUKE CTSA COLLABORATIONU42RR018877 · NCRR · UNIVERSITY OF MISSOURI-COLUMBIA · PI RILEY, LELA K. · 2003 to 2011
$13.4M
Reproduction of Transgenic Pigs by Nuclear TransplantationR01RR013438 · NCRR · UNIVERSITY OF MISSOURI-COLUMBIA · PI PRATHER, RANDALL S · 1998 to 2010
$2.4M
P23H Rhodopsin Mutant Swine Model of Reninitis PigmentosaR21EY020647 · NEI · UNIVERSITY OF LOUISVILLE · PI KAPLAN, HENRY JERROLD, ROSS, JASON W · 2011 to 2012
$421k
A Large Animal Model of SMAR21NS078299 · NINDS · UNIVERSITY OF MISSOURI-COLUMBIA · PI LORSON, MONIQUE A · 2012 to 2013
$409k
Large Animal Model of Spinal Muscular AtrophyR21NS059510 · NINDS · UNIVERSITY OF MISSOURI-COLUMBIA · PI LORSON, MONIQUE A · 2008 to 2009
$360k
NCRR NIH HHS R01 RR013438NCRR NIH HHS R21 RR039232NCRR NIH HHS U42 RR018877NEI NIH HHS R21 EY020647NIH HHS OD011140NIH HHS U42 OD011140NINDS NIH HHS R21 NS059510NINDS NIH HHS R21 NS078299PHS HHS R21 NSO595101
6 · The paper itself

Abstract

Although pigs are used widely as models of human disease, their utility as models has been enhanced by genetic engineering. Initially, transgenes were added randomly to the genome, but with the application of homologous recombination, zinc finger nucleases, and transcription activator-like effector nuclease (TALEN) technologies, now most any genetic change that can be envisioned can be completed. To date these genetic modifications have resulted in animals that have the potential to provide new insights into human diseases for which a good animal model did not exist previously. These new animal models should provide the preclinical data for treatments that are developed for diseases such as Alzheimer's disease, cystic fibrosis, retinitis pigmentosa, spinal muscular atrophy, diabetes, and organ failure. These new models will help to uncover aspects and treatments of these diseases that were otherwise unattainable. The focus of this review is to describe genetically engineered pigs that have resulted in models of human diseases.

Indexed as

Animals, Genetically ModifiedDisease Models, AnimalAnimalsGenetic EngineeringHumansSwinecloninggenetic engineeringswine

Identifiers

PMID25387017
PMCPMC4460601
OpenAlexW2135349690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.